![Shigeki Moriguchi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shigeki Moriguchi
Directeur/Membre du Conseil chez
ASAHI INTECC CO., LTD.
Profil
Shigeki Moriguchi is the founder of Neusignal Therapeutics Co. Ltd. (founded in 2022) and Brain Innovation KK (founded in 2018).
At Brain Innovation KK, he holds the title of Director & Chief Scientific Officer.
Currently, Mr. Moriguchi is working as an Independent Outside Director at Asahi Intecc Co., Ltd. (since 2022).
Postes actifs de Shigeki Moriguchi
| Sociétés | Poste | Début |
|---|---|---|
| ASAHI INTECC CO., LTD. | Directeur/Membre du Conseil | 01/09/2024 |
Brain Innovation KK
 Brain Innovation KK Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of dementia, psychiatric disorders and brain diseases | Fondateur | 08/08/2018 |
Anciens postes connus de Shigeki Moriguchi
| Sociétés | Poste | Fin |
|---|
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Asahi Intecc Co., Ltd.
 Asahi Intecc Co., Ltd. Medical SpecialtiesHealth Technology Manufactures and sells medical diagnostic equipment & stainless steel wire and wire material | Health Technology |
Brain Innovation KK
Brain Innovation KK Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of dementia, psychiatric disorders and brain diseases | Health Technology |
